News | July 01, 2007

Vertebroplasty Market Growing Strong

July 2, 2007 - Analysis of the minimally invasive vertebral compression fracture (VCF) treatment market by Millennium Research Group (MRG) reveals that the U.S. market is expected to grow at double-digit rates over the next five years. This expected growth is due in part to the popularity of kyphoplasty and the emergence of new devices and competitors in the vertebroplasty market. Both kyphoplasty and vertebroplasty are minimally invasive, nonsurgical procedures, which involve the insertion of a special bone needle through the posterior soft tissues and the injection of a small amount of orthopedic cement through the needle into the vertebral body in order to relieve the pain caused by vertebral compression fractures.

"Currently, Kyphon is the largest player in the minimally invasive VCF treatment market with its kyphoplasty products. However, all the competitors including Kyphon, Stryker, ArthroCare, Cardinal Health, and Cook continue to improve the safety, efficacy, and ease-of-use of their vertebroplasty products," said Kevin Flewwelling, Senior Analyst at MRG. "Furthermore, newer competitors like Medtronic Spinal and Biologics, Spine Wave, and Spineology are providing practitioners new treatment alternatives to choose from."

For more information: www.mrg.net

Related Content

Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...